Filing Details

Accession Number:
0001209191-12-019091
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-20 10:40:12
Reporting Period:
2012-03-16
Filing Date:
2012-03-20
Accepted Time:
2012-03-20 10:40:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1093649 Idenix Pharmaceuticals Inc IDIX Pharmaceutical Preparations (2834) 450478605
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1428086 Paul Fanning C/O Idenix Pharmaceuticals, Inc.
60 Hampshire Street
Cambridge MA 02139
Svp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-16 30,000 $2.41 31,300 No 4 M Direct
Common Stock Disposition 2012-03-16 30,000 $11.04 1,300 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-03-16 30,000 $0.00 30,000 $2.41
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-11-08 No 4 M Direct
Footnotes
  1. This option is fully vested.